A comprehensive view of Gennova Biopharmaceuticals. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
PharmaJet announces successful trial of GEMCOVAC-OM, a novel self-amplifying mRNA vaccine for COVID19, delivered intradermally through its needle-free Tropis ID System; trial showed a significant boost in immune response against the Omicron variant
Published:
April 29, 2024
by PharmaJet Inc.
|
PharmaJet announces its Tropis intradermal delivery system is the exclusive delivery device for nucleic acid COVID-19 vaccines from Zydus Lifesciences and Gennova Biopharmaceuticals
Published:
June 28, 2023
by PharmaJet Inc.
|
Ask us about our Health Care Sector market view